11.13.12
WuXi Pharma Tech
3Q Revenues: $125.8 million (+21%)
3Q Earnings: $213 million (+3%)
YTD Revenues: $374.3 million (+25%)
YTD Earnings: $62.8 million (+9%)
Comments: Laboratory Services were $98.9 million in the quarter, up 26%. China-based Lab Services increased 32% to $77.0 million. U.S.-based Lab Services were up 6% to $21.9 million. Manufacturing services were $26.9 million, up 7%.
3Q Revenues: $125.8 million (+21%)
3Q Earnings: $213 million (+3%)
YTD Revenues: $374.3 million (+25%)
YTD Earnings: $62.8 million (+9%)
Comments: Laboratory Services were $98.9 million in the quarter, up 26%. China-based Lab Services increased 32% to $77.0 million. U.S.-based Lab Services were up 6% to $21.9 million. Manufacturing services were $26.9 million, up 7%.